Sana Biotechnology Inc
NASDAQ:SANA
Income Statement
Earnings Waterfall
Sana Biotechnology Inc
Income Statement
Sana Biotechnology Inc
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(382)
|
(276)
|
(359)
|
(357)
|
(208)
|
(299)
|
(302)
|
(273)
|
(325)
|
(368)
|
(284)
|
(293)
|
(320)
|
(249)
|
(307)
|
(273)
|
(213)
|
(213)
|
(240)
|
|
| Selling, General & Administrative |
(27)
|
(34)
|
(47)
|
(50)
|
(53)
|
(59)
|
(61)
|
(72)
|
(74)
|
(72)
|
(76)
|
(73)
|
(73)
|
(73)
|
(68)
|
(64)
|
(59)
|
(53)
|
(49)
|
|
| Research & Development |
(176)
|
(191)
|
(244)
|
(249)
|
(279)
|
(307)
|
(330)
|
(286)
|
(280)
|
(281)
|
(270)
|
(269)
|
(258)
|
(246)
|
(234)
|
(218)
|
(198)
|
(167)
|
(144)
|
|
| Other Operating Expenses |
(179)
|
(51)
|
(68)
|
(58)
|
125
|
67
|
89
|
85
|
29
|
(15)
|
61
|
49
|
11
|
70
|
(6)
|
9
|
45
|
7
|
(47)
|
|
| Operating Income |
(382)
N/A
|
(276)
+28%
|
(359)
-30%
|
(357)
+1%
|
(208)
+42%
|
(299)
-44%
|
(302)
-1%
|
(273)
+10%
|
(325)
-19%
|
(368)
-13%
|
(284)
+23%
|
(293)
-3%
|
(320)
-9%
|
(249)
+22%
|
(307)
-24%
|
(273)
+11%
|
(213)
+22%
|
(213)
+0%
|
(240)
-13%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
4
|
5
|
7
|
9
|
10
|
11
|
12
|
12
|
10
|
8
|
6
|
4
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(5)
|
0
|
0
|
(46)
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
(4)
|
(5)
|
(5)
|
(4)
|
0
|
1
|
|
| Pre-Tax Income |
(382)
N/A
|
(275)
+28%
|
(358)
-30%
|
(356)
+1%
|
(207)
+42%
|
(298)
-44%
|
(300)
-1%
|
(269)
+10%
|
(320)
-19%
|
(362)
-13%
|
(276)
+24%
|
(283)
-3%
|
(309)
-9%
|
(245)
+21%
|
(306)
-25%
|
(267)
+13%
|
(209)
+22%
|
(252)
-21%
|
(234)
+7%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(382)
|
(275)
|
(358)
|
(356)
|
(207)
|
(298)
|
(300)
|
(269)
|
(320)
|
(362)
|
(276)
|
(283)
|
(309)
|
(245)
|
(306)
|
(267)
|
(209)
|
(252)
|
(234)
|
|
| Net Income (Common) |
(381)
N/A
|
(275)
+28%
|
(358)
-30%
|
(356)
+1%
|
(208)
+42%
|
(298)
-44%
|
(300)
-1%
|
(269)
+10%
|
(320)
-19%
|
(362)
-13%
|
(276)
+24%
|
(283)
-3%
|
(309)
-9%
|
(245)
+21%
|
(306)
-25%
|
(267)
+13%
|
(209)
+22%
|
(252)
-21%
|
(234)
+7%
|
|
| EPS (Diluted) |
-2.31
N/A
|
-1.44
+38%
|
-1.97
-37%
|
-2.14
-9%
|
-1.11
+48%
|
-1.58
-42%
|
-1.58
N/A
|
-1.43
+9%
|
-1.69
-18%
|
-1.89
-12%
|
-1.37
+28%
|
-1.46
-7%
|
-1.42
+3%
|
-1.04
+27%
|
-1.29
-24%
|
-1.16
+10%
|
-0.88
+24%
|
-1.06
-20%
|
-0.89
+16%
|
|